Redirecting T-cell specificity by introducing a tumor-specific chimeric antigen receptorJENA, Bipulendu; DOTTI, Gianpietro; COOPER, Laurence J. N et al.Blood. 2010, Vol 116, Num 7, pp 1035-1044, issn 0006-4971, 10 p.Article

Chimeric antigen receptors for the adoptive T cell therapy of hematologic malignancies : Recent Progress in Gene TherapyDAVILA, Marco L; BOUHASSIRA, Diana C. G; PARK, Jae H et al.International journal of hematology. 2014, Vol 99, Num 4, pp 361-371, issn 0925-5710, 11 p.Article

Generation of CD19-chimeric antigen receptor modified CD8⁺ T cells derived from virus-specific central memory T cellsTERAKURA, Seitaro; YAMAMOTO, Tori N; GARDNER, Rebecca A et al.Blood. 2012, Vol 119, Num 1, pp 72-82, issn 0006-4971, 11 p.Article

Considerations for the Clinical Application of Chimeric Antigen Receptor T Cells: Observations from a Recombinant DNA Advisory Committee Symposium Held June 15, 2010ERTL, Hildegund C. J; ZAIA, John; ROSENBERG, Steven A et al.Cancer research (Chicago, Ill.). 2011, Vol 71, Num 9, pp 3175-3181, issn 0008-5472, 7 p.Article

Generation of antitumor responses by genetic modification of primary human T cells with a chimeric NKG2D receptorTONG ZHANG; BARBER, Amorette; SENTMAN, Charles L et al.Cancer research (Baltimore). 2006, Vol 66, Num 11, pp 5927-5933, issn 0008-5472, 7 p.Article

Engineering T cells for cancer therapyMANSOOR, W; GILHAM, D. E; THISTLETHWAITE, F. C et al.British journal of cancer. 2005, Vol 93, Num 10, pp 1085-1091, issn 0007-0920, 7 p.Article

Chimeric Antigen Receptor―Modified T Cells for Acute Lymphoid LeukemiaGRUPP, Stephan A; KALOS, Michael; MILONE, Michael C et al.The New England journal of medicine. 2013, Vol 368, Num 16, pp 1509-1518, issn 0028-4793, 10 p.Article

Chimeric Antigen Receptor-Modified T Cells in Chronic Lymphoid LeukemiaPORTER, David L; LEVINE, Bruce L; KALOS, Michael et al.The New England journal of medicine. 2011, Vol 365, Num 8, pp 725-733, issn 0028-4793, 9 p.Article

CD28 costimulation provided through a CD19-specific chimeric antigen receptor enhances in vivo persistence and antitumor efficacy of adoptively transferred T cellsKOWOLIK, Claudia M; TOPP, Max S; GONZALEZ, Sergio et al.Cancer research (Baltimore). 2006, Vol 66, Num 22, pp 10995-11004, issn 0008-5472, 10 p.Article

A Chimeric Receptor with NKG2D Specificity Enhances Natural Killer Cell Activation and Killing of Tumor CellsCHANG, Yu-Hsiang; CONNOLLY, John; SHIMASAKI, Noriko et al.Cancer research (Chicago, Ill.). 2013, Vol 73, Num 6, pp 1777-1786, issn 0008-5472, 10 p.Article

The B-cell tumor-associated antigen ROR1 can be targeted with T cells modified to express a ROR1-specific chimeric antigen receptorHUDECEK, Michael; SCHMITT, Thomas M; WOOD, Brent et al.Blood. 2010, Vol 116, Num 22, pp 4532-4541, issn 0006-4971, 10 p.Article

A foundation for universal T-cell based immunotherapy: T cells engineered to express a CD19-specific chimeric-antigen-receptor and eliminate expression of endogenous TCRTORIKAI, Hiroki; REIK, Andreas; LEE, Dean A et al.Blood. 2012, Vol 119, Num 24, pp 5697-5705, issn 0006-4971, 9 p.Article

The Future Is Now: Chimeric Antigen Receptors as New Targeted Therapies for Childhood Cancer : Progress in Pediatric CancerLEE, Daniel W; BARRETT, David M; MACKALL, Crystal et al.Clinical cancer research (Print). 2012, Vol 18, Num 10, pp 2780-2790, issn 1078-0432, 11 p.Article

B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD 19 chimeric-antigen-receptor-transduced T cellsKOCHENDERFER, James N; DUDLEY, Mark E; YANG, James C et al.Blood. 2012, Vol 119, Num 12, pp 2709-2720, issn 0006-4971, 12 p.Article

Complement activated by chimeric anti-folate receptor antibodies is an efficient effector system to control ovarian carcinomaMACOR, Paolo; MEZZANZANICA, Delia; COSSETTI, Chiara et al.Cancer research (Baltimore). 2006, Vol 66, Num 7, pp 3876-3883, issn 0008-5472, 8 p.Article

Phenotypic and Functional Attributes of Lentivirus-modified CD19-specific Human CD8⁺ Central Memory T Cells Manufactured at Clinical ScaleXIULI WANG; NARANJO, Araceli; JENSEN, Michael C et al.Journal of immunotherapy (1997). 2012, Vol 35, Num 9, pp 689-701, issn 1524-9557, 13 p.Article

IL-12 Release by Engineered T Cells Expressing Chimeric Antigen Receptors Can Effectively Muster an Antigen-Independent Macrophage Response on Tumor Cells That Have Shut Down Tumor Antigen ExpressionCHMIELEWSKI, Markus; KOPECKY, Caroline; HOMBACH, Andreas A et al.Cancer research (Chicago, Ill.). 2011, Vol 71, Num 17, pp 5697-5706, issn 0008-5472, 10 p.Article

Multifactorial T-cell Hypofunction That Is Reversible Can Limit the Efficacy of Chimeric Antigen Receptor―Transduced Human T cells in Solid TumorsMOON, Edmund K; WANG, Liang-Chuan; JUNE, Carl H et al.Clinical cancer research (Print). 2014, Vol 20, Num 16, pp 4262-4273, issn 1078-0432, 12 p.Article

T-cell immunotherapy with a chimeric receptor against CD38 is effective in eliminating myeloma cellsMIHARA, K; BHATTACHARYYA, J; KITANAKA, A et al.Leukemia. 2012, Vol 26, Num 2, pp 365-367, issn 0887-6924, 3 p.Article

Targeted immunotherapy of cancer with CAR T cells: achievements and challengesLIPOWSKA-BHALLA, Grazyna; GILHAM, David E; HAWKINS, Robert E et al.Cancer immunology and immunotherapy. 2012, Vol 61, Num 7, pp 953-962, issn 0340-7004, 10 p.Article

The T-Body Approach : Redirecting T Cells with Antibody SpecificityESHHAR, Z.Handbook of experimental pharmacology. 2008, Vol 181, pp 329-342, issn 0171-2004, 14 p.Article

Chimeric NKG2D receptor-bearing T cells as immunotherapy for ovarian cancerBARBER, Amorette; TONG ZHANG; DEMARS, Leslie R et al.Cancer research (Baltimore). 2007, Vol 67, Num 10, pp 5003-5008, issn 0008-5472, 6 p.Article

Chimeric T-cell receptors : new challenges for targeted immunotherapy in hematologic malignanciesBIAGI, Ettore; MARIN, Virna; ATTIANESE, Greta Maria Paola Giordano et al.Haematologica (Roma). 2007, Vol 92, Num 3, pp 381-388, issn 0390-6078, 8 p.Article

Genetic modification of primary natural killer cells overcomes inhibitory signals and induces specific killing of leukemic cellsIMAI, Chihaya; IWAMOTO, Shotaro; CAMPANA, Dario et al.Blood. 2005, Vol 106, Num 1, pp 376-383, issn 0006-4971, 8 p.Article

Redirected primary T cells harboring a chimeric receptor require costimulation for their antigen-specific activationFRIEDMANN-MORVINSKI, Dinorah; BENDAVID, Alain; WAKS, Tova et al.Blood. 2005, Vol 105, Num 8, pp 3087-3093, issn 0006-4971, 7 p.Article